Literature DB >> 22579755

Epigenomic regulation of bile acid metabolism: emerging role of transcriptional cofactors.

Zachary Smith1, Daniel Ryerson, Jongsook Kim Kemper.   

Abstract

The traditional role of bile acids is to simply facilitate absorption and digestion of lipid nutrients, but bile acids also act as endocrine signaling molecules that activate nuclear and membrane receptors to control integrative metabolism and energy balance. The mechanisms by which bile acid signals are integrated to regulate target genes are, however, largely unknown. Recently emerging evidence has shown that transcriptional cofactors sense metabolic changes and modulate gene transcription by mediating reversible epigenomic post-translational modifications (PTMs) of histones and chromatin remodeling. Importantly, targeting these epigenomic changes has been a successful approach for treating human diseases, especially cancer. Here, we review emerging roles of transcriptional cofactors in the epigenomic regulation of liver metabolism, especially focusing on bile acid metabolism. Targeting PTMs of histones and chromatin remodelers, together with the bile acid-activated receptors, may provide new therapeutic options for bile acid-related disease, such as cholestasis, obesity, diabetes, and entero-hepatic cancers.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22579755      PMCID: PMC3473118          DOI: 10.1016/j.mce.2012.04.008

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  111 in total

Review 1.  Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways.

Authors:  Joseph T Rodgers; Carles Lerin; Zachary Gerhart-Hines; Pere Puigserver
Journal:  FEBS Lett       Date:  2007-11-26       Impact factor: 4.124

Review 2.  FXR signaling in metabolic disease.

Authors:  Yanqiao Zhang; Peter A Edwards
Journal:  FEBS Lett       Date:  2007-11-20       Impact factor: 4.124

Review 3.  H3K27 demethylases, at long last.

Authors:  Tomek Swigut; Joanna Wysocka
Journal:  Cell       Date:  2007-10-05       Impact factor: 41.582

4.  Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis.

Authors:  Sabyasachi Sanyal; Ann Båvner; Anna Haroniti; Lisa-Mari Nilsson; Thomas Lundåsen; Stefan Rehnmark; Michael Robin Witt; Curt Einarsson; Iannis Talianidis; Jan-Ake Gustafsson; Eckardt Treuter
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-25       Impact factor: 11.205

Review 5.  Targeting farnesoid X receptor for liver and metabolic disorders.

Authors:  Stefano Fiorucci; Gianni Rizzo; Annibale Donini; Eleonora Distrutti; Luca Santucci
Journal:  Trends Mol Med       Date:  2007-06-27       Impact factor: 11.951

6.  Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver.

Authors:  Jiansheng Huang; Jahangir Iqbal; Pradip K Saha; Jun Liu; Lawrence Chan; M Mahmood Hussain; David D Moore; Li Wang
Journal:  Hepatology       Date:  2007-07       Impact factor: 17.425

7.  Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis.

Authors:  Young Joo Park; Mohammed Qatanani; Steven S Chua; Jennifer L LaRey; Stacy A Johnson; Mitsuhiro Watanabe; David D Moore; Yoon Kwang Lee
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

Review 8.  Bile acid sequestrants and the treatment of type 2 diabetes mellitus.

Authors:  Bart Staels; Folkert Kuipers
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Insights in the regulation of cholesterol 7alpha-hydroxylase gene reveal a target for modulating bile acid synthesis.

Authors:  Nico Mitro; Cristina Godio; Emma De Fabiani; Elena Scotti; Andrea Galmozzi; Federica Gilardi; Donatella Caruso; Ana Belen Vigil Chacon; Maurizio Crestani
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

10.  SIRT1 deacetylates and positively regulates the nuclear receptor LXR.

Authors:  Xiaoling Li; Songwen Zhang; Gil Blander; Jeanette G Tse; Monty Krieger; Leonard Guarente
Journal:  Mol Cell       Date:  2007-10-12       Impact factor: 17.970

View more
  12 in total

1.  Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression.

Authors:  Masayuki Nagahashi; Kazuaki Takabe; Runping Liu; Kesong Peng; Xiang Wang; Yun Wang; Nitai C Hait; Xuan Wang; Jeremy C Allegood; Akimitsu Yamada; Tomoyoshi Aoyagi; Jie Liang; William M Pandak; Sarah Spiegel; Phillip B Hylemon; Huiping Zhou
Journal:  Hepatology       Date:  2015-03-09       Impact factor: 17.425

2.  A postprandial FGF19-SHP-LSD1 regulatory axis mediates epigenetic repression of hepatic autophagy.

Authors:  Sangwon Byun; Young-Chae Kim; Yang Zhang; Bo Kong; Grace Guo; Junichi Sadoshima; Jian Ma; Byron Kemper; Jongsook Kim Kemper
Journal:  EMBO J       Date:  2017-04-26       Impact factor: 11.598

3.  Bile acids as global regulators of hepatic nutrient metabolism.

Authors:  Phillip B Hylemon; Kazuaki Takabe; Mikhail Dozmorov; Masayuki Nagahashi; Huiping Zhou
Journal:  Liver Res       Date:  2017-04-26

4.  Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Cζ is critical for epigenomic regulation of liver metabolic genes.

Authors:  Sunmi Seok; Deepthi Kanamaluru; Zhen Xiao; Daniel Ryerson; Sung-E Choi; Kelly Suino-Powell; H Eric Xu; Timothy D Veenstra; Jongsook Kim Kemper
Journal:  J Biol Chem       Date:  2013-07-03       Impact factor: 5.157

5.  Farnesoid X receptor-induced lysine-specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity.

Authors:  Young-Chae Kim; Sungsoon Fang; Sangwon Byun; Sunmi Seok; Byron Kemper; Jongsook Kim Kemper
Journal:  Hepatology       Date:  2015-02-27       Impact factor: 17.425

Review 6.  Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics.

Authors:  Yajun Duan; Ke Gong; Suowen Xu; Feng Zhang; Xianshe Meng; Jihong Han
Journal:  Signal Transduct Target Ther       Date:  2022-08-02

7.  Enhancer deletion and allelic effects define a regulatory molecular mechanism at the VLDLR cholesterol GWAS locus.

Authors:  James P Davis; Swarooparani Vadlamudi; Tamara S Roman; Monica Zeynalzadeh; Apoorva K Iyengar; Karen L Mohlke
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

Review 8.  Bile formation and secretion.

Authors:  James L Boyer
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

Review 9.  A shift in paradigm towards human biology-based systems for cholestatic-liver diseases.

Authors:  Fozia Noor
Journal:  J Physiol       Date:  2015-11-04       Impact factor: 5.182

Review 10.  Long noncoding RNAs-a new dimension in the molecular architecture of the bile acid/FXR pathway.

Authors:  Yonghe Ma; Jamie Harris; Ping Li; Haiming Cao
Journal:  Mol Cell Endocrinol       Date:  2021-02-01       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.